Mattia Galli On Genomadix Cube Test: A Rapid Genetic Test to Predict The Response to Clopidogrel
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal, reposted from Mater Dei General Hospital on LinkedIn:
”Would you take a life-saving drug knowing that in one case out of three this does not work? Probably not.
In the heart of Rome, one of the first centers in Italy to finally offer the possibility of predicting the response to the most widely used anti-caking drug, clopidogrel, with a simple and rapid genetic test.
The result of the test is integrated with the most up-to-date international recommendations on the subject, to which I had the honor of contributing, to offer a personalized assessment and improve the prognosis of patients in each specific clinical context.
After years of scientific research, it is time to turn science into real benefits for a more targeted and personalized care of cardiovascular patients.”
Mater Dei General Hospital shared on LinkedIn:
”What is the Genomadix Cube test?
It is a simple and non-invasive genetic test that helps to understand how our body responds to some fundamental drugs in cardiology, such as antiplatelet drugs that inhibit P2Y12 (clopidogrel, prasugrel or ticagrelor)
Let’s find out more with Dr. Mattia Galli
Info and reservations
Tel. 06 83 803”
Read the full article in JACC.
Article: International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update
Authors: Dominick J. Angiolillo, Mattia Galli, Dimitrios Alexopoulos, Daniel Aradi, Deepak L. Bhatt, Laurent Bonello, Davide Capodanno, Larisa H. Cavallari, Jean-Philippe Collet, Thomas Cuisset, Jose Luis Ferreiro, Francesco Franchi, Tobias Geisler, C. Michael Gibson, Diana A. Gorog, Paul A. Gurbel, Young-Hoon Jeong, Rossella Marcucci, Jolanta M. Siller-Matula, Roxana Mehran, Franz-Josef Neumann, Naveen L. Pereira, Konstantinos D. Rizas, Fabiana Rollini, Derek Y.F. So, Gregg W. Stone, Robert F. Storey, Udaya S. Tantry, Jurrien Ten Berg, Dietmar Trenk, Marco Valgimigli, Ron Waksman, Dirk Sibbing
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:46Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal